References

  1. Nweze JA, Eke IE, Nweze EI. HIV/AIDS in sub-Saharan Africa: current status, challenges and prospects. Asian Pac J Trop Dis. 2017;7(4):239-256.

  2. Azia IN, Mukumbang FC, van-Wyk V. Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. South African Journal of HIV Medicine. 2016;(17):1608-9698. PubMed | Google Scholar

  3. Awoyemi AA, Olusegun EO. HIV epidemiology in Nigeria Saudi. Journal of Biological Sciences. 2018;25(4):697-703.

  4. WHO. 15 facts on HIV treatment sale-up and new WHO ARV guidelines 2013. Accessed on 27/7/2018

  5. Centre for Disease Control and Prevention. Vital signs: HIV prevention through care A and treatment-United States. Morb Mortal Wkly Rep. 2011;60(47):1618-1623. Google Scholar

  6. Rusine J, Asiimwe-Kateera B, van de Wijgert J, Boer KR, Mukantwali E, Karita E et al. Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda. PLoS One. 2013;(8)8:e64345. PubMed | Google Scholar

  7. Bennett DE, Camacho RJ, Otelia D, Kuritzkes DR. Drug resistance mutation for surveillance of HIV-1 transmitted drug resistance. PLoS One. 2012;3:e4724.

  8. Odaibo GN, Okonkwo P, Adewole IF, Olaleye DO. Pattern of HIV-1 Drug Resistance among Adults on ART. World Journal of AIDS. 2013;3:327–34. Google Scholar

  9. Ryscavage P, Anderson E, Sutton S, Reddy STB. Clinical outcomes of adolescents and young adults in HIV care. J Acquir Immune Defic Syndr. 2011;58(2):193–7. PubMed | Google Scholar

  10. Dean V. HIV/AIDS among minor race and ethnicity in the United States 199-2003. Jounal Natl Med Assoc. 2005;97:S5–12.

  11. Cancedda C. The detrimental effect of adversity on HIV outcomes in the era of combined anti-retroviral therapy. World J AIDS. 2012;2:338–46. Google Scholar

  12. Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010;10:111. PubMed | Google Scholar

  13. Patrick OE, John Arute E. Adherence of HIV/AIDS patients to antiretroviral therapy in a tertiary health facility in Benin City. African J Pharm Pharmacol. 2008;2(7):145–52. Google Scholar

  14. Grace R, Usman IA. Adherence to highly active antiretroviral therapy and its challenges in people living with human immunodeficiency virus infection in Keffi, Nigeria. J AIDS HIV Res. 2013;5(2):52–8. PubMed | Google Scholar

  15. Iliyasu Z, Kabiru M, Abubakar I. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano Nigeria. Niger J Med. 2005;14(3):290-294. PubMed | Google Scholar

  16. Fogarty L, Roter D, Larson S, Burke J, Gillespie J. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Education and Counselling. 2002;46(2):93-103. PubMed | Google Scholar

  17. Mee P, Fielding K, Charalambous S, Churchyard G et al. Evaluation of WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS. 2008;22(15):971–7. PubMed | Google Scholar

  18. Uzochukwu BS, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, Chukwuogo OI. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Oxford Journals Medicine & Health Health Policy and Planning. 2008;24(3):189-196. PubMed | Google Scholar

  19. Issifou Y, Dadje E, Bayaki S et al. Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS at regional hospital of Sokode, Togo. BMC Public Health. 2014;14:1308. PubMed | Google Scholar